Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, today announced that reported diluted earnings per share equaled $0.20 in the fourth quarter of fiscal 2014, compared to $0.17 in the fourth quarter of fiscal 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC